Tanner Pharma Group
Kathrin Khadra is a Co-Founder and Tech specialist at RYVER.AI, focusing on cutting-edge synthetic data technology for the healthcare sector since January 2021. Additionally, Kathrin serves as a Fellow at Sigma Squared Society, contributing to impactful ventures. Previous experience includes a Master thesis at TUM on causal regularization in deep learning, a working student role at Fraunhofer Venture managing the SDG track, and co-founding Helfen.München, a successful non-profit initiative. Kathrin has also held positions in innovation consulting at Bosch and BCG, as well as software development for surgical robotics. Academic qualifications include a Master's degree from the Technical University of Munich, and fellowships involving entrepreneurship at the University of Oxford.
This person is not in any offices
Tanner Pharma Group
Over the past 20 years, Tanner has developed a portfolio of service offerings focused on improving the global access to medicines. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their access programs, and procure and distribute comparator drugs and supplies for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality. Through our global network, determined and resourceful team, decades of distribution experience and passion for health equity, we’ve been able to positively impact thousands of lives through access to medicine. And our journey is only just beginning. Our locations: US, UK, Brazil, Switzerland, Ireland